step semaglutide FDA Approves Oral for Weight Loss Semaglutide 2·4 mg once a

Secondary outcomes included the proportion of patients who achieved 5% or more, 10% or more, 15% or more and 20% or more weight loss at 3 and 6 months and the percentage of weight loss for those with or without type 2 diabetes

Due to their impact on weight and other health benefits, some of these drugs may be used off-label (for a different indication than they were approved to treat) for weight loss in people with overweight or obesity

Chronic nausea or bloating can make social interactions and work responsibilities more stressful, which may increase irritability

Contact your GP if you experience worsening symptoms